# Valero Energy Corp: financial statements, quarterly

VLO · NYSE · CIK 1035002 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vlo.md) · [Financials](/companies/vlo/financials.md) · [Filings](/companies/vlo/filings.md) · [Insiders](/companies/vlo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vlo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [35.4 d](/filings/0001628280-26-011499.md) | [31.8](/filings/0001035002-25-000017.md) | [34.5](/filings/0001035002-25-000061.md) | [32.9](/filings/0001628280-25-046072.md) | [30.8 d](/filings/0001628280-26-011499.md) | [30.3](/filings/0001628280-26-028690.md) | [29.9](/filings/0001628280-26-050937.md) | [32.2](/filings/0001628280-26-067679.md) | [30.4 d](/filings/0001628280-26-011499.md) | [32.4](/filings/0001628280-26-028690.md) | [44.5](/filings/0001628280-26-050937.md) | [46.1](/filings/0001628280-26-067679.md) |
| Cost of revenue | $bn | [33.5 d](/filings/0001628280-26-011499.md) | [29.8](/filings/0001035002-25-000017.md) | [33.1](/filings/0001035002-25-000061.md) | [32.1](/filings/0001628280-25-046072.md) | [30.1 d](/filings/0001628280-26-011499.md) | [29.8](/filings/0001628280-26-028690.md) | [28.6](/filings/0001628280-26-050937.md) | [30.4](/filings/0001628280-26-067679.md) | [28.5 d](/filings/0001628280-26-011499.md) | [30.3](/filings/0001628280-26-028690.md) | [39.0](/filings/0001628280-26-050937.md) | [36.7](/filings/0001628280-26-067679.md) |
| Gross profit | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $bn | [1.6 d](/filings/0001628280-26-011499.md) | [1.7](/filings/0001035002-25-000017.md) | [1.2](/filings/0001035002-25-000061.md) | [0.5](/filings/0001628280-25-046072.md) | [0.3 d](/filings/0001628280-26-011499.md) | [(0.9)](/filings/0001628280-26-028690.md) | [1.0](/filings/0001628280-26-050937.md) | [1.5](/filings/0001628280-26-067679.md) | [1.6 d](/filings/0001628280-26-011499.md) | [1.7](/filings/0001628280-26-028690.md) | [5.2](/filings/0001628280-26-050937.md) | [9.1](/filings/0001628280-26-067679.md) |
| Interest expense | $bn | [0.1 d](/filings/0001628280-26-011499.md) | [0.1](/filings/0001035002-25-000017.md) | [0.1](/filings/0001035002-25-000061.md) | [0.1](/filings/0001628280-25-046072.md) | [0.1 d](/filings/0001628280-26-011499.md) | [0.1](/filings/0001628280-26-028690.md) | [0.1](/filings/0001628280-26-050937.md) | [0.1](/filings/0001628280-26-067679.md) | [0.1 d](/filings/0001628280-26-011499.md) | [0.1](/filings/0001628280-26-028690.md) | [0.1](/filings/0001628280-26-050937.md) | [0.1](/filings/0001628280-26-067679.md) |
| Income tax | $bn | [0.3 d](/filings/0001628280-26-011499.md) | [0.4](/filings/0001035002-25-000017.md) | [0.3](/filings/0001035002-25-000061.md) | [0.1](/filings/0001628280-25-046072.md) | [(0.0) d](/filings/0001628280-26-011499.md) | [(0.3)](/filings/0001628280-26-028690.md) | [0.3](/filings/0001628280-26-050937.md) | [0.4](/filings/0001628280-26-067679.md) | [0.4 d](/filings/0001628280-26-011499.md) | [0.4](/filings/0001628280-26-028690.md) | [1.1](/filings/0001628280-26-050937.md) | [2.1](/filings/0001628280-26-067679.md) |
| Net income | $bn | [1.2 d](/filings/0001628280-26-011499.md) | [1.2](/filings/0001035002-25-000017.md) | [0.9](/filings/0001035002-25-000061.md) | [0.4](/filings/0001628280-25-046072.md) | [0.3 d](/filings/0001628280-26-011499.md) | [(0.6)](/filings/0001628280-26-028690.md) | [0.7](/filings/0001628280-26-050937.md) | [1.1](/filings/0001628280-26-067679.md) | [1.1 d](/filings/0001628280-26-011499.md) | [1.3](/filings/0001628280-26-028690.md) | [3.7](/filings/0001628280-26-050937.md) | [6.8](/filings/0001628280-26-067679.md) |
| Diluted EPS | $ per share | not reported | [3.75](/filings/0001035002-25-000017.md) | [2.71](/filings/0001035002-25-000061.md) | [1.14](/filings/0001628280-25-046072.md) | not reported | [(1.90)](/filings/0001628280-26-028690.md) | [2.28](/filings/0001628280-26-050937.md) | [3.53](/filings/0001628280-26-067679.md) | not reported | [4.22](/filings/0001628280-26-028690.md) | [12.62](/filings/0001628280-26-050937.md) | [23.89](/filings/0001628280-26-067679.md) |
| Basic EPS | $ per share | not reported | [3.75](/filings/0001035002-25-000017.md) | [2.71](/filings/0001035002-25-000061.md) | [1.14](/filings/0001628280-25-046072.md) | not reported | [(1.90)](/filings/0001628280-26-028690.md) | [2.28](/filings/0001628280-26-050937.md) | [3.54](/filings/0001628280-26-067679.md) | not reported | [4.22](/filings/0001628280-26-028690.md) | [12.62](/filings/0001628280-26-050937.md) | [23.90](/filings/0001628280-26-067679.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [5.4](/filings/0001035002-25-000005.md) | [4.9](/filings/0001035002-24-000022.md) | [5.2](/filings/0001035002-24-000051.md) | [5.2](/filings/0001035002-24-000056.md) | [4.7](/filings/0001628280-26-011499.md) | [4.6](/filings/0001035002-25-000017.md) | [4.5](/filings/0001035002-25-000061.md) | [4.8](/filings/0001628280-25-046072.md) | [4.7](/filings/0001628280-26-067679.md) | [5.7](/filings/0001628280-26-028690.md) | [7.9](/filings/0001628280-26-050937.md) | [9.8](/filings/0001628280-26-067679.md) |
| Current assets | $bn | [26.2](/filings/0001035002-25-000005.md) | [25.7](/filings/0001035002-24-000022.md) | [27.1](/filings/0001035002-24-000051.md) | [24.0](/filings/0001035002-24-000056.md) | [23.7](/filings/0001628280-26-011499.md) | [23.6](/filings/0001035002-25-000017.md) | [23.8](/filings/0001035002-25-000061.md) | [23.5](/filings/0001628280-25-046072.md) | [23.2](/filings/0001628280-26-067679.md) | [27.8](/filings/0001628280-26-028690.md) | [30.7](/filings/0001628280-26-050937.md) | [33.6](/filings/0001628280-26-067679.md) |
| Total assets | $bn | [63.1](/filings/0001035002-25-000005.md) | [62.6](/filings/0001035002-24-000022.md) | [63.6](/filings/0001035002-24-000051.md) | [60.4](/filings/0001035002-24-000056.md) | [60.1](/filings/0001628280-26-011499.md) | [59.2](/filings/0001035002-25-000017.md) | [59.4](/filings/0001035002-25-000061.md) | [58.6](/filings/0001628280-25-046072.md) | [58.0](/filings/0001628280-26-067679.md) | [62.1](/filings/0001628280-26-028690.md) | [64.7](/filings/0001628280-26-050937.md) | [68.0](/filings/0001628280-26-067679.md) |
| Current liabilities | $bn | [16.8](/filings/0001035002-25-000005.md) | [16.1](/filings/0001035002-24-000022.md) | [18.3](/filings/0001035002-24-000051.md) | [15.3](/filings/0001035002-24-000056.md) | [15.5](/filings/0001628280-26-011499.md) | [15.1](/filings/0001035002-25-000017.md) | [14.7](/filings/0001035002-25-000061.md) | [14.7](/filings/0001628280-25-046072.md) | [14.1](/filings/0001628280-26-067679.md) | [17.7](/filings/0001628280-26-028690.md) | [18.7](/filings/0001628280-26-050937.md) | [19.5](/filings/0001628280-26-067679.md) |
| Long-term debt | $bn | [9.2](/filings/0001035002-24-000007.md) | not reported | not reported | not reported | [8.1](/filings/0001035002-25-000005.md) | not reported | not reported | not reported | [8.3](/filings/0001628280-26-011499.md) | not reported | not reported | not reported |
| Current portion of debt | $bn | [1.4](/filings/0001035002-25-000005.md) | [0.9](/filings/0001035002-24-000022.md) | [1.0](/filings/0001035002-24-000051.md) | [1.0](/filings/0001035002-24-000056.md) | [0.7](/filings/0001628280-26-011499.md) | [0.5](/filings/0001035002-25-000017.md) | [0.4](/filings/0001035002-25-000061.md) | [0.9](/filings/0001628280-25-046072.md) | [0.9](/filings/0001628280-26-067679.md) | [1.0](/filings/0001628280-26-028690.md) | [0.9](/filings/0001628280-26-050937.md) | [1.0](/filings/0001628280-26-067679.md) |
| Shareholders' equity | $bn | [26.3](/filings/0001035002-25-000005.md) | [26.1](/filings/0001035002-24-000022.md) | [25.4](/filings/0001035002-24-000051.md) | [25.3](/filings/0001035002-24-000056.md) | [24.5](/filings/0001628280-26-011499.md) | [23.5](/filings/0001035002-25-000017.md) | [24.1](/filings/0001035002-25-000061.md) | [23.8](/filings/0001628280-25-046072.md) | [23.7](/filings/0001628280-26-067679.md) | [23.9](/filings/0001628280-26-028690.md) | [25.0](/filings/0001628280-26-050937.md) | [28.0](/filings/0001628280-26-067679.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,239 d](/filings/0001628280-26-011499.md) | [1,846](/filings/0001035002-25-000017.md) | [2,472 d](/filings/0001035002-25-000061.md) | [1,295 d](/filings/0001628280-25-046072.md) | [1,070 d](/filings/0001628280-26-011499.md) | [952](/filings/0001628280-26-028690.md) | [936 d](/filings/0001628280-26-050937.md) | [1,881 d](/filings/0001628280-26-067679.md) | [2,057 d](/filings/0001628280-26-011499.md) | [1,390](/filings/0001628280-26-028690.md) | [5,580 d](/filings/0001628280-26-050937.md) | [6,932 d](/filings/0001628280-26-067679.md) |
| Capital expenditure | $m | not reported | [661](/filings/0001035002-25-000017.md) | [420](/filings/0001035002-25-000061.md) | [429](/filings/0001628280-25-046072.md) | [547 d](/filings/0001035002-25-000005.md) | [659](/filings/0001035002-25-000017.md) | [407](/filings/0001035002-25-000061.md) | [409](/filings/0001628280-25-046072.md) | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [346 d](/filings/0001628280-26-011499.md) | [356](/filings/0001035002-25-000017.md) | [347 d](/filings/0001035002-25-000061.md) | [342 d](/filings/0001628280-25-046072.md) | [339 d](/filings/0001628280-26-011499.md) | [356](/filings/0001628280-26-028690.md) | [354 d](/filings/0001628280-26-050937.md) | [351 d](/filings/0001628280-26-067679.md) | [344 d](/filings/0001628280-26-011499.md) | [359](/filings/0001628280-26-028690.md) | [355 d](/filings/0001628280-26-050937.md) | [345 d](/filings/0001628280-26-067679.md) |
| Share repurchases | $m | [956 d](/filings/0001628280-26-011499.md) | [1,023](/filings/0001035002-25-000017.md) | [1,033 d](/filings/0001035002-25-000061.md) | [560 d](/filings/0001628280-25-046072.md) | [259 d](/filings/0001628280-26-011499.md) | [274](/filings/0001628280-26-028690.md) | [338 d](/filings/0001628280-26-050937.md) | [922 d](/filings/0001628280-26-067679.md) | [1,064 d](/filings/0001628280-26-011499.md) | [573](/filings/0001628280-26-028690.md) | [2,263 d](/filings/0001628280-26-050937.md) | [3,362 d](/filings/0001628280-26-067679.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [369](/filings/0001035002-24-000022.md) | [358](/filings/0001035002-24-000051.md) | [349](/filings/0001035002-24-000056.md) | [331](/filings/0001035002-25-000017.md) | [324](/filings/0001035002-25-000061.md) | [318](/filings/0001628280-25-046072.md) | [314](/filings/0001628280-26-028690.md) | [312](/filings/0001628280-26-050937.md) | [309](/filings/0001628280-26-067679.md) | [298](/filings/0001628280-26-028690.md) | [294](/filings/0001628280-26-050937.md) | [285](/filings/0001628280-26-067679.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 278,884,400 at 2026-10-23, from the cover of the [10-Q filed 2026-10-28](/filings/0001628280-26-067679.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 02:33 ET. No prices; not investment advice.